Health Trials

About this trial

This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia (FM), Lupus, chronic pelvic pain, and chronic low back pain learn effective strategies for reducing pain, disability and other problems that can come with fibromyalgia, Lupus, chronic pelvic pain, and chronic low back pain (such as depression or anxiety).

Eligibility criteria

Qualifiers

Able to read, write and speak English

Internet access and audio-visual conferencing capability (e.g., Zoom meetings by phone or computer) in the home

Physician diagnosis of fibromyalgia

OR: meet 2016 American College of Rheumatology (ACR) Criteria for FM: Widespread pain index score is ≥ 7 and symptom severity scale score is ≥ 5, or widespread pain index score is 4 to 6 and symptom severity score is ≥ 9

Disqualifiers

Indication of a co-occurring (non-fibromyalgia OR non-lupus) cause of chronic pain (e.g., inflammatory arthritis, other autoimmune disorders, spinal cord injury, cancer)

Currently receiving cognitive-behavioral therapy or other psychological therapies for pain

Open litigation regarding chronic pain in the past 1 year, as assessed in preliminary study screening.

Inability to provide informed consent and complete study procedures (e.g., indications of suspected major cognitive impairment via observations of study staff during consenting) that would preclude comprehension or participation in study protocols.

Trial design

Treatments tested in this trial

  • Brief pain exposure therapy (BPET)

Treatment groups

125 Participants
are divided into 1 treatment group

Locations

1
University of Michigan48109, Ann ArborMichigan, United States

Sponsors and collaborators

University of Michigan

Lead sponsor

Source ClinicalTrials.gov